CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Budesonide in autoimmune liver disease
DOI 10.1055/s-2004-827070
Bibliografische Angaben
Nachweis in CareLit
Autor:innenG Treiber, A Csepregi, P Malfertheiner
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2004
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Prednis(ol)one (PRD) alone or in combination with azathioprine (AZA) is the treatment for autoimmune hepatitis (AIH). Budesonide (BUD) has been reported to be an alternative treatment of choice. Data, however, are very limited and highly controversial. Patients and methods: Fifteen patients (F:M=11:4; mean age 51±14 ys.) with AIH were treated with BUD (Budenofalk) of 9mg/day and were followed up for 32 t…
Zitieren
Zitierempfehlung
G Treiber, A Csepregi, P Malfertheiner (2004) Budesonide in autoimmune liver disease. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-2004-827070
Mit CareLit weiterarbeiten